Pathway enrichment assessments determined that the top four enriched pathways were hypertrophic cardiomyopathy, dilated cardiomyopathy, neurotrophin signaling pathway, and adrenergic signaling in cardiomyocytes. The gene discussed is BDNF; the disease is hypertrophic cardiomyopathy.